Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesAnti-Cancer Agent Xeloda and Avastin Obtained Approval for Additional Indication of Colorectal Cancer
Chugai Pharmaceutical Co., 09/25/09
Chugai Pharmaceutical Co., Ltd. announced that Chugai has obtained approval for the additional indication of its oral fluoropyrimidine anti–cancer agent capecitabine [Product name: "Xeloda Tablets 300" (hereafter, "Xeloda")], in combination with oxaliplatin, in the treatment of patients with "advanced or refractory colorectal cancer who are not candidates for curative surgery". Approval was received on September 2009 from the Ministry of Health, Labour and Welfare.
Today in Drug Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Boston Scientific Announces FDA Clearance and CE Mark for WallFlex Fully Covered Esophageal Stent
Boston Scientific, 11/24/09
Dendreon Receives FDA Acknowledgement of Complete Response
Dendreon Coproration, 11/23/09
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09
Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09
Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis
Cephalon, 11/24/09
Sponsor
Article Search
Sponsor